Global Pneumonia Vaccine Sales Market Report 2021

1 Pneumonia Vaccine Market Overview

• 1.1 Pneumonia Vaccine Product Scope
• 1.2 Pneumonia Vaccine Segment by Type
  • 1.2.1 Global Pneumonia Vaccine Sales by Type (2016 & 2021 & 2027)
  • 1.2.2 Pneumococcal Conjugate Vaccine (PCV13)
  • 1.2.3 Pneumococcal Polysaccharide Vaccine (PPSV23)
• 1.3 Pneumonia Vaccine Segment by Application
  • 1.3.1 Global Pneumonia Vaccine Sales Comparison by Application (2016 & 2021 & 2027)
  • 1.3.2 Pneumonia
  • 1.3.3 Meningitis
  • 1.3.4 Sepsis
• 1.4 Pneumonia Vaccine Market Estimates and Forecasts (2016-2027)
  • 1.4.1 Global Pneumonia Vaccine Market Size in Value Growth Rate (2016-2027)
  • 1.4.2 Global Pneumonia Vaccine Market Size in Volume Growth Rate (2016-2027)
  • 1.4.3 Global Pneumonia Vaccine Price Trends (2016-2027)

2 Pneumonia Vaccine Estimates and Forecasts by Region

• 2.1 Global Pneumonia Vaccine Market Size by Region: 2016 VS 2021 VS 2027
• 2.2 Global Pneumonia Vaccine Retrospective Market Scenario by Region (2016-2021)
  • 2.2.1 Global Pneumonia Vaccine Sales Market Share by Region (2016-2021)
  • 2.2.2 Global Pneumonia Vaccine Revenue Market Share by Region (2016-2021)
• 2.3 Global Pneumonia Vaccine Market Estimates and Forecasts by Region (2022-2027)
  • 2.3.1 Global Pneumonia Vaccine Sales Estimates and Forecasts by Region (2022-2027)
  • 2.3.2 Global Pneumonia Vaccine Revenue Forecast by Region (2022-2027)
• 2.4 Geographic Market Analysis: Market Facts & Figures
  • 2.4.1 North America Pneumonia Vaccine Estimates and Projections (2016-2027)
  • 2.4.2 Europe Pneumonia Vaccine Estimates and Projections (2016-2027)
  • 2.4.3 China Pneumonia Vaccine Estimates and Projections (2016-2027)
  • 2.4.4 Japan Pneumonia Vaccine Estimates and Projections (2016-2027)
  • 2.4.5 Southeast Asia Pneumonia Vaccine Estimates and Projections (2016-2027)
  • 2.4.6 India Pneumonia Vaccine Estimates and Projections (2016-2027)

3 Global Pneumonia Vaccine Competition Landscape by Players

• 3.1 Global Top Pneumonia Vaccine Players by Sales (2016-2021)
• 3.2 Global Top Pneumonia Vaccine Players by Revenue (2016-2021)
• 3.3 Global Pneumonia Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Pneumonia Vaccine as of 2020)
• 3.4 Global Pneumonia Vaccine Average Price by Company (2016-2021)
• 3.5 Manufacturers Pneumonia Vaccine Manufacturing Sites, Area Served, Product Type
• 3.6 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Global Pneumonia Vaccine Market Size by Type

• 4.1 Global Pneumonia Vaccine Historic Market Review by Type (2016-2021)
  • 4.1.1 Global Pneumonia Vaccine Sales Market Share by Type (2016-2021)
  • 4.1.2 Global Pneumonia Vaccine Revenue Market Share by Type (2016-2021)
  • 4.1.3 Global Pneumonia Vaccine Price by Type (2016-2021)
• 4.2 Global Pneumonia Vaccine Market Estimates and Forecasts by Type (2022-2027)
  • 4.2.1 Global Pneumonia Vaccine Sales Forecast by Type (2022-2027)
  • 4.2.2 Global Pneumonia Vaccine Revenue Forecast by Type (2022-2027)
  • 4.2.3 Global Pneumonia Vaccine Price Forecast by Type (2022-2027)

5 Global Pneumonia Vaccine Market Size by Application

• 5.1 Global Pneumonia Vaccine Historic Market Review by Application (2016-2021)
  • 5.1.1 Global Pneumonia Vaccine Sales Market Share by Application (2016-2021)
  • 5.1.2 Global Pneumonia Vaccine Revenue Market Share by Application (2016-2021)
  • 5.1.3 Global Pneumonia Vaccine Price by Application (2016-2021)
• 5.2 Global Pneumonia Vaccine Market Estimates and Forecasts by Application (2022-2027)
  • 5.2.1 Global Pneumonia Vaccine Sales Forecast by Application (2022-2027)
  • 5.2.2 Global Pneumonia Vaccine Revenue Forecast by Application (2022-2027)
  • 5.2.3 Global Pneumonia Vaccine Price Forecast by Application (2022-2027)

6 North America Pneumonia Vaccine Market Facts & Figures

• 6.1 North America Pneumonia Vaccine Sales by Company
  • 6.1.1 North America Pneumonia Vaccine Sales by Company (2016-2021)
  • 6.1.2 North America Pneumonia Vaccine Revenue by Company (2016-2021)
• 6.2 North America Pneumonia Vaccine Sales Breakdown by Type
  • 6.2.1 North America Pneumonia Vaccine Sales Breakdown by Type (2016-2021)
  • 6.2.2 North America Pneumonia Vaccine Sales Breakdown by Type (2022-2027)
• 6.3 North America Pneumonia Vaccine Sales Breakdown by Application
  • 6.3.1 North America Pneumonia Vaccine Sales Breakdown by Application (2016-2021)
  • 6.3.2 North America Pneumonia Vaccine Sales Breakdown by Application (2022-2027)

7 Europe Pneumonia Vaccine Market Facts & Figures

• 7.1 Europe Pneumonia Vaccine Sales by Company
  • 7.1.1 Europe Pneumonia Vaccine Sales by Company (2016-2021)
  • 7.1.2 Europe Pneumonia Vaccine Revenue by Company (2016-2021)
• 7.2 Europe Pneumonia Vaccine Sales Breakdown by Type
  • 7.2.1 Europe Pneumonia Vaccine Sales Breakdown by Type (2016-2021)
  • 7.2.2 Europe Pneumonia Vaccine Sales Breakdown by Type (2022-2027)
• 7.3 Europe Pneumonia Vaccine Sales Breakdown by Application
  • 7.3.1 Europe 130 Sales Breakdown by Application (2016-2021)
  • 7.3.2 Europe 130 Sales Breakdown by Application (2022-2027)

8 China Pneumonia Vaccine Market Facts & Figures

• 8.1 China Pneumonia Vaccine Sales by Company
  • 8.1.1 China Pneumonia Vaccine Sales by Company (2016-2021)
  • 8.1.2 China Pneumonia Vaccine Revenue by Company (2016-2021)
• 8.2 China Pneumonia Vaccine Sales Breakdown by Type
  • 8.2.1 China Pneumonia Vaccine Sales Breakdown by Type (2016-2021)
  • 8.2.2 China Pneumonia Vaccine Sales Breakdown by Type (2022-2027)
• 8.3 China Pneumonia Vaccine Sales Breakdown by Application
  • 8.3.1 China 241 Sales Breakdown by Application (2016-2021)
  • 8.3.2 China 241 Sales Breakdown by Application (2022-2027)

9 Japan Pneumonia Vaccine Market Facts & Figures

• 9.1 Japan Pneumonia Vaccine Sales by Company
  • 9.1.1 Japan Pneumonia Vaccine Sales by Company (2016-2021)
  • 9.1.2 Japan Pneumonia Vaccine Revenue by Company (2016-2021)
• 9.2 Japan Pneumonia Vaccine Sales Breakdown by Type
  • 9.2.1 Japan Pneumonia Vaccine Sales Breakdown by Type (2016-2021)
  • 9.2.2 Japan Pneumonia Vaccine Sales Breakdown by Type (2022-2027)
• 9.3 Japan Pneumonia Vaccine Sales Breakdown by Application
  • 9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
  • 9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)

10 Southeast Asia Pneumonia Vaccine Market Facts & Figures

• 10.1 Southeast Asia Pneumonia Vaccine Sales by Company
  • 10.1.1 Southeast Asia Pneumonia Vaccine Sales by Company (2016-2021)
  • 10.1.2 Southeast Asia Pneumonia Vaccine Revenue by Company (2016-2021)
• 10.2 Southeast Asia Pneumonia Vaccine Sales Breakdown by Type
  • 10.2.1 Southeast Asia Pneumonia Vaccine Sales Breakdown by Type (2016-2021)
  • 10.2.2 Southeast Asia Pneumonia Vaccine Sales Breakdown by Type (2022-2027)
• 10.3 Southeast Asia Pneumonia Vaccine Sales Breakdown by Application
  • 10.3.1 Southeast Asia K Doses Sales Breakdown by Application (2016-2021)
  • 10.3.2 Southeast Asia K Doses Sales Breakdown by Application (2022-2027)

11 India Pneumonia Vaccine Market Facts & Figures

• 11.1 India Pneumonia Vaccine Sales by Company
  • 11.1.1 India Pneumonia Vaccine Sales by Company (2016-2021)
  • 11.1.2 India Pneumonia Vaccine Revenue by Company (2016-2021)
• 11.2 India Pneumonia Vaccine Sales Breakdown by Type
  • 11.2.1 India Pneumonia Vaccine Sales Breakdown by Type (2016-2021)
  • 11.2.2 India Pneumonia Vaccine Sales Breakdown by Type (2022-2027)
• 11.3 India Pneumonia Vaccine Sales Breakdown by Application
  • 11.3.1 India Pneumonia Vaccine Sales Breakdown by Application (2016-2021)
  • 11.3.2 India Pneumonia Vaccine Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in Pneumonia Vaccine Business

• 12.1 Pfizer Inc.
  • 12.1.1 Pfizer Inc. Corporation Information
  • 12.1.2 Pfizer Inc. Business Overview
  • 12.1.3 Pfizer Inc. Pneumonia Vaccine Sales, Revenue and Gross Margin (2016-2021)
  • 12.1.4 Pfizer Inc. Pneumonia Vaccine Products Offered
  • 12.1.5 Pfizer Inc. Recent Development
• 12.2 Glaxosmithkline Plc.
  • 12.2.1 Glaxosmithkline Plc. Corporation Information
  • 12.2.2 Glaxosmithkline Plc. Business Overview
  • 12.2.3 Glaxosmithkline Plc. Pneumonia Vaccine Sales, Revenue and Gross Margin (2016-2021)
  • 12.2.4 Glaxosmithkline Plc. Pneumonia Vaccine Products Offered
  • 12.2.5 Glaxosmithkline Plc. Recent Development
• 12.3 Merck & Co., Inc.
  • 12.3.1 Merck & Co., Inc. Corporation Information
  • 12.3.2 Merck & Co., Inc. Business Overview
  • 12.3.3 Merck & Co., Inc. Pneumonia Vaccine Sales, Revenue and Gross Margin (2016-2021)
  • 12.3.4 Merck & Co., Inc. Pneumonia Vaccine Products Offered
  • 12.3.5 Merck & Co., Inc. Recent Development
• 12.4 Sanofi Pasteur
  • 12.4.1 Sanofi Pasteur Corporation Information
  • 12.4.2 Sanofi Pasteur Business Overview
  • 12.4.3 Sanofi Pasteur Pneumonia Vaccine Sales, Revenue and Gross Margin (2016-2021)
  • 12.4.4 Sanofi Pasteur Pneumonia Vaccine Products Offered
  • 12.4.5 Sanofi Pasteur Recent Development
• 12.5 Serum Institute of India Pvt. Ltd.
  • 12.5.1 Serum Institute of India Pvt. Ltd. Corporation Information
  • 12.5.2 Serum Institute of India Pvt. Ltd. Business Overview
  • 12.5.3 Serum Institute of India Pvt. Ltd. Pneumonia Vaccine Sales, Revenue and Gross Margin (2016-2021)
  • 12.5.4 Serum Institute of India Pvt. Ltd. Pneumonia Vaccine Products Offered
  • 12.5.5 Serum Institute of India Pvt. Ltd. Recent Development
• 12.6 Johnson & Johnson
  • 12.6.1 Johnson & Johnson Corporation Information
  • 12.6.2 Johnson & Johnson Business Overview
  • 12.6.3 Johnson & Johnson Pneumonia Vaccine Sales, Revenue and Gross Margin (2016-2021)
  • 12.6.4 Johnson & Johnson Pneumonia Vaccine Products Offered
  • 12.6.5 Johnson & Johnson Recent Development
• 12.7 Astellas Pharma Inc.
  • 12.7.1 Astellas Pharma Inc. Corporation Information
  • 12.7.2 Astellas Pharma Inc. Business Overview
  • 12.7.3 Astellas Pharma Inc. Pneumonia Vaccine Sales, Revenue and Gross Margin (2016-2021)
  • 12.7.4 Astellas Pharma Inc. Pneumonia Vaccine Products Offered
  • 12.7.5 Astellas Pharma Inc. Recent Development
• 12.8 Astrazeneca Plc.
  • 12.8.1 Astrazeneca Plc. Corporation Information
  • 12.8.2 Astrazeneca Plc. Business Overview
  • 12.8.3 Astrazeneca Plc. Pneumonia Vaccine Sales, Revenue and Gross Margin (2016-2021)
  • 12.8.4 Astrazeneca Plc. Pneumonia Vaccine Products Offered
  • 12.8.5 Astrazeneca Plc. Recent Development
• 12.9 CSL Limited
  • 12.9.1 CSL Limited Corporation Information
  • 12.9.2 CSL Limited Business Overview
  • 12.9.3 CSL Limited Pneumonia Vaccine Sales, Revenue and Gross Margin (2016-2021)
  • 12.9.4 CSL Limited Pneumonia Vaccine Products Offered
  • 12.9.5 CSL Limited Recent Development
• 12.10 Emergent Biosolutions
  • 12.10.1 Emergent Biosolutions Corporation Information
  • 12.10.2 Emergent Biosolutions Business Overview
  • 12.10.3 Emergent Biosolutions Pneumonia Vaccine Sales, Revenue and Gross Margin (2016-2021)
  • 12.10.4 Emergent Biosolutions Pneumonia Vaccine Products Offered
  • 12.10.5 Emergent Biosolutions Recent Development

13 Pneumonia Vaccine Manufacturing Cost Analysis

• 13.1 Pneumonia Vaccine Key Raw Materials Analysis
  • 13.1.1 Key Raw Materials
  • 13.1.2 Key Raw Materials Price Trend
  • 13.1.3 Key Suppliers of Raw Materials
• 13.2 Proportion of Manufacturing Cost Structure
• 13.3 Manufacturing Process Analysis of Pneumonia Vaccine
• 13.4 Pneumonia Vaccine Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers

• 14.1 Marketing Channel
• 14.2 Pneumonia Vaccine Distributors List
• 14.3 Pneumonia Vaccine Customers

15 Market Dynamics

• 15.1 Pneumonia Vaccine Market Trends
• 15.2 Pneumonia Vaccine Drivers
• 15.3 Pneumonia Vaccine Market Challenges
• 15.4 Pneumonia Vaccine Market Restraints

16 Research Findings and Conclusion

17 Appendix

• 17.1 Research Methodology
  • 17.1.1 Methodology/Research Approach
  • 17.1.2 Data Source
• 17.2 Author List